The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran | Zendy

Mohammadreza Amirsadri | Zendy; Sarah Mousavi | Zendy; Ali Karimipour | Zendy

Open Access

The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran

Author(s) -

Mohammadreza Amirsadri,

Sarah Mousavi,

Ali Karimipour

Publication year - 2019

Publication title -

daru journal of pharmaceutical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.645

H-Index - 42

eISSN - 2008-2231

pISSN - 1560-8115

DOI - 10.1007/s40199-019-00292-1

Subject(s) - medicine , cost effectiveness analysis , cost–utility analysis , cost effectiveness , psychological intervention , quality adjusted life year , cost–benefit analysis , venous thromboembolism , emergency medicine , surgery , thrombosis , risk analysis (engineering) , psychiatry , biology , ecology

Moderate to high risk medical inpatients are at increased risk of Venous Thromboembolism (VTE). The present study aims to investigate the cost-effectiveness and cost-utility of using Enoxaparin compared to Heparin in VTE prophylaxis in medical inpatients, from Iranian payer's perspective.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research